LIS - Code |
Test Name |
Test Methodology |
Specimen Type |
Container |
Volume |
Transport/ Temperature |
TAT |
Cut off |
Test Requistion form |
Status/ Remarks/comments |
Clinical use |
Cancer Type |
Test component |
2114 |
ColoComprehensive |
Fragment Length And Next Generation Sequencing (NGS) |
Tumour FFPE block |
Plastic Box or Bag |
|
Room Temperature |
12 days |
|
|
MSI+BRAF+KRAS+NRAS |
1. Prognosis (5 yr. survival) 2. To suspect for Lynch syndrome. 2. Patient eligibility for Cetuximab/ Panitumumab, Vemurafenib. |
Colon Cancer |
OncoCEPT Solid (DNA)+ MSI |
Fresh Tissue |
RNAlater (contact lab for the tube) |
|
0-4C, shipped with cool pack |
|
|
|
Whole Blood in EDTA (for MSI testing) |
|
4ml |
Room temp, temperature should not exceed 30'c
|
|
|
|
|
|
|
G2195 |
IHC, ER-PR & Her2 By IHC |
Immunohistochemistry (IHC) |
Tumour FFPE block |
Plastic Box or Bag |
|
Room Temperature |
5 days |
|
|
Immunohistochemistry of ER, PR and Her2 |
Classification of tumor |
Breast |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
T2413 |
HER2 By FISH |
FISH |
Tumour FFPE block |
Plastic Box or Bag |
|
Room Temperature |
7 days |
|
|
Her2 |
Classification of tumor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
T3901 |
HER2 By Digital PCR |
Digital PCR |
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
7 days |
|
|
Her2 |
Classification of tumor |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
T2021 |
BRCA1&2 By NGS - BRCA1&2 |
Next Generation Sequencing (NGS) |
Whole Blood EDTA |
Purple / Lavender |
4ml |
0-4C |
30 days |
|
|
BRCA1/2 |
1. To confirm HBOC syndrome. 2. Ovarian/ Prostate cancer patient's eligibility for Olaparib. |
BRCA1/2 by NGS |
|
|
|
0-4C |
BRCA1/2 by NGS |
|
|
|
|
|
|
|
|
|
|
|
|
|
2113 |
Somatic BRCA 1&2 |
Next Generation Sequencing (NGS) |
Fresh Tissue |
RNAlater (contact lab for the tube) |
|
0-4C, Shipped with Cool Pack |
|
|
|
|
1. Ovarian/ Prostate cancer patient's eligibility for Olaparib. |
OncoCEPT Solid Comprehensive |
|
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2101 |
OncoCEPT - Solid |
Next Generation Sequencing (NGS) |
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
12 days |
|
|
Mutations: ESR1, PIK3CA, PTEN. Copy number variation: CCND1. |
To choose optimal treatment for ER+ CA breast, not responding to hormone therapy. |
|
|
|
NGS Sequencing |
Fresh Tissue |
RNAlater (contact lab for the tube) |
|
0-4C, shipped with Cool Pack |
|
|
|
|
|
|
|
T3015 |
EGFR By NGS |
Next Generation Sequencing (NGS) |
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
12 days |
|
|
EGFR All Exons |
Eligibility of patient for TKIs |
Lungs |
OncoCEPT Solid (DNA) |
|
|
Fresh Tissue |
RNAlater (contact lab for the tube) |
|
0-4C, shipped with Cool Pack |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2215 |
EGFR T790M |
Digital PCR |
Whole Blood Streck Tube |
Roche Tube (contact lab for the tube) |
10.0 ml |
0-4C |
5 days |
|
|
EGFR T790 Liquid Biopsy |
Eligibility of patient for TKIs |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1135 |
OncoCEPT-Liquid |
Next Generation Sequencing (NGS) |
Whole Blood Streck Tube |
Roche Tube (contact lab for the tube) |
10.0 ml |
0-4C |
12 days |
|
|
ALK, BRAF, EGFR, ERBB2, KRAS, MAP2K1, MET, NRAS, PIK3CA, ROS1, and TP53 |
Eligibility of patient for TKIs/ Resistance to TKIs |
|
G2408 |
HPV 16/18 |
Real time PCR |
Cervical swab/swab |
VTM Falcon Tube |
|
Room Temperature |
2 days |
|
|
HPV 16/18 |
Cervical cancer diagnosis |
Cervical cancer |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
T2560 |
HPV-high risk strains |
Next Generation Sequencing (NGS) |
Cervical Swab |
VTM Falcon Tube |
|
Room Temperature |
10 days |
|
|
HPV-High Risk Strains |
Cervical cancer diagnosis and prognosis of oral cancer. |
|
2101 |
OncoCEPT Solid Comprehensive |
Next Generation Sequencing (NGS) |
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
15 days |
|
|
|
For specific cases, especially non lung, non breast, CUP tumors. |
|
|
|
|
Fresh Tissue |
RNAlater (contact lab for the tube) |
|
0-4C, Shipped with Cool Pack |
|
|
|
|
|
|
|
2103 |
KRAS+NRAS+BRAF Oncocept Solid - Onco.colon |
NGS Sequencing |
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
12 days |
|
|
|
Eligibility of patient for Cetuximab, Panitumumab and anti BRAF mAb |
|
OncoCEPT Solid (DNA) |
|
|
Fresh Tissue |
RNAlater (contact lab for the tube) |
|
0-4C, Shipped with Cool Pack |
|
|
|
|
|
|
|
2104 |
GIST Panel Oncocept Solid - Onco.GIST |
NGS Sequencing |
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
12 days |
|
|
|
Eligibility of patients for targeted therapy. |
|
OncoCEPT Solid (DNA) |
|
|
Fresh Tissue |
RNAlater (contact lab for the tube) |
|
0-4C, Shipped with Cool Pack |
|
|
|
|
|
|
|
2106 |
Thyroid Cancer Panel OncoCEPT Solid - Onco.Thyroid |
NGS Sequencing |
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
|
|
|
|
Eligibility of patient for targeted therapy. |
|
OncoCEPT Solid |
|
|
Fresh Tissue |
RNAlater (contact lab for the tube) |
|
0-4C, Shipped with Cool Pack |
|
|
|
|
|
|
|
2107 |
Oncocept Solid Breast Cancer Panel (ER+Her2-) - Onco.Breast |
NGS Sequencing |
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
|
|
|
|
Eligibility of patients for targeted therapy. |
|
OncoCEPT Solid |
|
|
Fresh Tissue |
RNAlater (contact lab for the tube) |
|
0-4C, Shipped with Cool Pack |
|
|
|
|
|
|
|
2110 |
HRR Gene Panel |
NGS Sequencing |
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
|
|
|
|
Eligibility of patient for Olaparib and screening of high risk family members. |
|
OncoCEPT Solid Comprehensive |
|
|
Fresh Tissue |
RNAlater (contact lab for the tube) |
|
0-4C, Shipped with Cool Pack |
|
|
|
|
|
|
|
2108 |
Oncocept Solid Single Gene - Onco.single |
NGS Sequencing |
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
|
|
|
|
|
|
OncoCEPT Solid (DNA) |
|
|
Fresh Tissue |
RNAlater (contact lab for the tube) |
|
0-4C, Shipped with Cool Pack |
|
|
|
|
|
|
|
2111 |
Microsatellite Instability - Onco.MSI |
|
Tumor FFPE Block |
Plastic Box or Bag |
5.0 ml |
Room Temperature |
7 days |
|
|
|
Eligibility of patients for Immunotherapy. |
|
|
|
|
|
Fresh Tissue |
RNAlater (contact lab for the tube) |
|
0-4C, Shipped with Cool Pack |
|
|
|
|
|
|
|
G2352 |
MMR IHC PANEL For MSI |
IHC |
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
|
|
|
|
Eligibility of patients for Immunotherapy. |
|
|
|
|
|
Formalin Fixed Tissue |
|
|
|
|
|
|
|
|
|
|
T4482 |
IHC Marker PDL1 |
IHC |
Tumor FFPE Block |
Plastic Box or Bag |
|
Room Temperature |
4 days |
|
|
|
|
|
|
T4594 |
ORION Whole Exome/ Comprehensive Cancer/ Inherited Cancer Germline |
Next Generation Sequencing (NGS) |
Whole Blood in EDTA |
|
5ml |
0-4C, Shipped with Cool Pack |
30 days |
|
|
MLH1, MSH2, MSH6, PMS2 |
To Confirm Lynch Syndrome |
Inherited Cancers |
|